Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.581
+0.001 (0.19%)
Nov 20, 2024, 4:00 PM EST - Market open
Elevation Oncology Employees
Elevation Oncology had 29 employees as of December 31, 2023. The number of employees decreased by 4 or -12.12% compared to the previous year.
Employees
29
Change (1Y)
-4
Growth (1Y)
-12.12%
Revenue / Employee
n/a
Profits / Employee
-$1,446,483
Market Cap
35.53M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 29 | -4 | -12.12% |
Dec 31, 2022 | 33 | 10 | 43.48% |
Dec 31, 2021 | 23 | 15 | 187.50% |
Dec 31, 2020 | 8 | - | - |
Related Stocks
Company Name | Employees |
---|---|
FibroGen | 486 |
Co-Diagnostics | 155 |
Carisma Therapeutics | 107 |
Beyond Air | 107 |
Tonix Pharmaceuticals Holding | 103 |
Precision Optics Corporation | 85 |
HCW Biologics | 45 |
OS Therapies | 4 |
ELEV News
- 15 days ago - Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements - PRNewsWire
- 6 weeks ago - Empery Asset Management's Strategic Acquisition in Elevation Oncology - GuruFocus
- 2 months ago - Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2 - PRNewsWire
- 2 months ago - Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - PRNewsWire
- 3 months ago - Undercovered Dozen: Elevation Oncology, Ivanhoe Mines, Union Pacific, Golub Capital + - Seeking Alpha
- 3 months ago - Why Is Penny Stock Elevation Oncology Trading Lower On Tuesday? - Benzinga
- 3 months ago - Elevation Oncology: Proving That No One Knows How To Interpret Early-Stage Clinical Results - Seeking Alpha
- 3 months ago - Elevation Oncology Reports Second Quarter 2024 Financial Results and Highlights Recent Business Achievements - PRNewsWire